EXtension of Tablo TrEatmeNt Duration Registry
NCT04912050 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33
Last updated 2022-08-12
Summary
Observational, retrospective and prospective, multicenter, post-market study of the Tablo Hemodialysis System in hospitalized participants with End-Stage Kidney Disease or Acute Kidney Injury who are prescribed renal replacement therapy \> 12 hours.
Conditions
- End Stage Renal Disease (ESRD)
- End Stage Renal Disease on Dialysis
- Acute Kidney Injury
Interventions
- DEVICE
-
Tablo Hemodialysis System
Renal Replacement Therapy between 12\< to ≤ 24 hours.
Sponsors & Collaborators
-
Outset Medical
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-25
- Primary Completion
- 2022-05-31
- Completion
- 2022-05-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Clinical Trial of IntensiVE Dialysis
NCT00649298 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Impact of Dialysis Treatment Type on Patient Survival
NCT00510549 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis
NCT00004429 ·Status: COMPLETED ·Phase: NA
-
24 Hour Use of the Wearable Artificial Kidney
NCT02280005 ·Status: COMPLETED ·Phase: NA
-
Uremic Toxin Removal and Hemodynamics in Long-hour Hemodialysis and Hemodiafiltration
NCT01328119 ·Status: COMPLETED ·Phase: NA
-
Steroid Impregnated Tape in the Treatment of Over-granulating Peritoneal Dialysis Exit Sites
NCT01996930 ·Status: COMPLETED ·Phase: PHASE3
-
Biological Determinants of Peritoneal Dialysis
NCT02694068 ·Status: COMPLETED
-
Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal
NCT07348536 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
NCT00004285 ·Status: COMPLETED ·Phase: NA
-
Protein-bound Uremic Retention Solutes and Long Nocturnal Hemodialysis: a Longitudinal Analysis
NCT00417339 ·Status: COMPLETED
-
Pharmacokinetics of Selected Antiinfectives During Sustained Low-efficiency Dialysis (SLED)
NCT02287493 ·Status: COMPLETED
-
Clinical Evaluation of the CM-1500 During Hemodialysis
NCT05125848 ·Status: COMPLETED ·Phase: NA
-
Optimisation of Anticoagulation in Patients on Nocturnal Hemodialysis
NCT05204810 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis)
NCT05540457 ·Status: COMPLETED ·Phase: NA
-
Comparison of Conventional Dialysis and the Allient System
NCT00788905 ·Status: UNKNOWN ·Phase: NA
-
Heparin-Free Chronic HemoDialysis Assessment
NCT06224140 ·Status: RECRUITING ·Phase: NA
-
Trial to Compare 1.0 Versus 2.0 mg Alteplase (tPA) Dosing in Restoring Hemodialysis Catheter Function
NCT02225782 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Post- and Pre-dilutional Hemodiafiltration in Hemodialysis Patients
NCT03288285 ·Status: COMPLETED
-
Native Kidney Denervation in Patients With End Stage Renal Disease
NCT00551304 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective Randomized Controlled Trial of Effect of Enhanced External Counter Pulsation to Arterial Stiffness in Chronic Hemodialysis Patient
NCT06608953 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System
NCT04198012 ·Status: COMPLETED ·Phase: NA
-
Resistance Exercise in Hemodialysis Patients
NCT06604221 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dexmedetomidine Pharmacokinetics During Continuous Renal Replacement Therapy (CRRT)
NCT01314209 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension
NCT02444442 ·Status: COMPLETED ·Phase: NA
-
Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients
NCT06492031 ·Status: COMPLETED